Although its uncharacteristically rough year in 2022 should not be ignored, JOHCM International Select has long-tenured, thoughtful managers consistently adhering to a creative, flexible approach. It retains its ability to outperform over time.
JOHCM International Select Institutional JOHIX
- NAV / 1-Day Return 23.26 / −0.77 %
- Total Assets 4.9 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.980%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Foreign Large Growth
- Investment Style Large Growth
- Min. Initial Investment 100,000
- Status Limited
- TTM Yield 1.76%
- Turnover 32%
USD | NAV as of Apr 19, 2024 | 1-Day Return as of Apr 19, 2024, 12:05 AM GMT+0
Morningstar’s Analysis JOHIX
Will JOHIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 27.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Zealand Pharma A/S | 2.92 | 154.0 Mil | Healthcare |
SK Hynix Inc | 2.84 | 150.0 Mil | Technology |
Disco Corp | 2.78 | 146.5 Mil | Technology |
Japan Exchange Group Inc | 2.73 | 143.9 Mil | Financial Services |
CRH PLC | 2.71 | 143.1 Mil | Basic Materials |
Ferguson PLC | 2.68 | 141.4 Mil | Industrials |
EQT AB Ordinary Shares | 2.68 | 141.2 Mil | Financial Services |
Novo Nordisk A/S Class B | 2.65 | 139.9 Mil | Healthcare |
NEC Corp | 2.65 | 139.7 Mil | Technology |
Hitachi Ltd | 2.63 | 138.5 Mil | Industrials |